Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nantong Richen Bioengineering is a specialized medical technology company focused on the development, production, and sale of diagnostic products for gastroenterology. The company is a global leader in Urea Breath Test (UBT) technology, providing both 13C and 14C urea breath test kits and the corresponding infrared spectrometers for the non-invasive detection of Helicobacter pylori. Operating as a key manufacturing and R&D hub for the Richen Group, the company maintains high-standard production facilities that comply with international quality certifications. Its products are widely utilized in hospitals and clinics worldwide to manage digestive health and prevent gastric diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nantong Richen Bioengineering.